DeepMed Research

Yonsei University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1885-01-01

Employees: 5K

Market Cap: -

Website: http://www.yonsei.ac.kr

Clinical Trials

Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases

Phase 2

Not yet recruiting

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Trastuzumab deruxtecan

First Posted Date: 2024-02-09

Last Posted Date: 2024-02-09

Lead Sponsor: Yonsei University

Target Recruit Count: 27

Registration Number: NCT06250777

Locations: 🇰🇷
Yonsei University Health system, Severance Hospital, Seoul, Korea, Republic of

AWARE Registry: Wearable ECG in Structural Heart Interventions

Not yet recruiting

Conditions: Patent Foramen Ovale
Atrial Septal Defect

First Posted Date: 2024-02-01

Last Posted Date: 2024-02-01

Lead Sponsor: Yonsei University

Target Recruit Count: 150

Registration Number: NCT06236776

Locations: 🇰🇷
Division of Cardiology, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea, Republic of

The Clinical Efficacy of the Video Laryngeal Mask (SaCoVLM™) in Geriatric Patients: A Comparison With a Conventional Supraglottic Airway Device (Ambu®Auragain™)

Not Applicable

Recruiting

Conditions: General Anesthesia
Elderly
Laryngeal Mask Airway

Interventions: Device: Ambu®Auragain™
Device: SaCoVLM™

First Posted Date: 2024-02-01

Last Posted Date: 2024-02-01

Lead Sponsor: Yonsei University

Target Recruit Count: 140

Registration Number: NCT06237504

Locations: 🇰🇷
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer

Recruiting

Conditions: Prostatic Neoplasm

Interventions: Drug: Ifosfamide/mesna

First Posted Date: 2024-02-01

Last Posted Date: 2024-02-01

Lead Sponsor: Yonsei University

Target Recruit Count: 60

Registration Number: NCT06236789

Locations: 🇰🇷
Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea, Seoul, Korea, Republic of

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease

Completed

Conditions: Symptomatic Peripheral Artery Disease With Femoropopliteal Lesions
Moderate or Severe Claudication (Rutherford Category 2 or 3)
Critical Limb Ischemia (Rutherford Category 4 or 5)

Interventions: Device: Implantation of Eluvia stent

First Posted Date: 2024-01-31

Last Posted Date: 2024-01-31

Lead Sponsor: Yonsei University

Target Recruit Count: 100

Registration Number: NCT06234280

Locations: 🇰🇷
Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

A Prospective, Multi-center Clinical Study to Establish Multi-Cancer Early Detection Platform Through the Analysis of Whole Genome Sequencing of Circulating DNA in Cancer Patients and Healthy Volunteers

Recruiting

Conditions: Healthy Volunteer
Invasive Cancer

First Posted Date: 2024-01-30

Last Posted Date: 2024-01-30

Lead Sponsor: Yonsei University

Target Recruit Count: 4000

Registration Number: NCT06231953

Locations: 🇰🇷
Yonsei Cancer Center, Yonsei Univ. College of Medicine, Seoul, Korea, Republic of

Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)

Not Applicable

Recruiting

Conditions: Polyvascular Disease
Peripheral Artery Disease

Interventions: Drug: Combination therapy of high-intensity dose rosuvastatin and ezetimibe
Drug: Rosuvastatin monotherapy for treat-to-target

First Posted Date: 2024-01-30

Last Posted Date: 2025-05-20

Lead Sponsor: Yonsei University

Target Recruit Count: 2462

Registration Number: NCT06231966

Locations: 🇰🇷
Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

Clinical Trial for Non-inferiority and Safety of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Patients With Hematologic Malignancies Who Require Prophylactic Hepatitis B Antiviral Treatment

Phase 4

Not yet recruiting

Conditions: Patients With Malignant Blood Disease Requiring Hepatitis B Antiviral Medication

Interventions: Drug: Vemlidy
Drug: Virreal

First Posted Date: 2024-01-24

Last Posted Date: 2024-01-24

Lead Sponsor: Yonsei University

Target Recruit Count: 100

Registration Number: NCT06221657

Comparison of Remimazolam-based MAC With Inhalation General Anesthesia Under the Guidance of an ANI Monitor During TURB

Not Applicable

Not yet recruiting

Conditions: Patients Undergoing Transurethral Resection of Bladder

Interventions: Drug: general anesthesia with sevoflurane
Drug: remimazolam based MAC

First Posted Date: 2024-01-22

Last Posted Date: 2024-01-22

Lead Sponsor: Yonsei University

Target Recruit Count: 46

Registration Number: NCT06217055

Locations: 🇰🇷
Yonsei university college of medicine, Seoul, Korea, Republic of

A Study on BReast Cancer Patient Care Using chAtbot and Video Education for Radiation Therapy (BRAVE)

Not Applicable

Completed

Conditions: Breast Neoplasms

Interventions: Other: Paper + Paper
Other: Video + Chatbot
Other: Video + Paper
Other: Paper + Chatbot

First Posted Date: 2024-01-17

Last Posted Date: 2024-01-17

Lead Sponsor: Yonsei University

Target Recruit Count: 148

Registration Number: NCT06207474

Locations: 🇰🇷
Yonsei Cancer Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy